跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
REVLIMID CAPSULES 25MG (SWITZERLAND) - PPB Drug Approval Details
Approvals
/
PPB
/
REVLIMID CAPSULES 25MG (SWITZERLAND)
Approved
STANDARD
REVLIMID CAPSULES 25MG (SWITZERLAND)
BRISTOL-MYERS SQUIBB PHARMA (HK) LTD
🇰🇪 Pharmacy and Poisons Board
Approval Date
Jun 21, 2024
Approval ID
d13fe05d3fcc5839
Company
BRISTOL-MYERS SQUIBB PHARMA (HK) LTD
Type
Standard
Approval Details
Approval Id
d13fe05d3fcc5839
Product Name
REVLIMID CAPSULES 25MG (SWITZERLAND)
Drug Hk Name
REVLIMID CAPSULES 25MG (SWITZERLAND)
Registration Code
HK-62180
Company Name
BRISTOL-MYERS SQUIBB PHARMA (HK) LTD
Company Detail Path
/organization/bristol-myers-squibb-pharma-company
Registration Category
Part 1, Schedule 1 & Schedule 3 Poison
Sale Requirement
Prescription only Medicines
Registration Date
2013-09-25
Company Address
RM 3001-3002 30/F, WINDSOR HOUSE, 311, GLOUCESTER RD., CAUSEWAY BAY, HONG KONG
Active Ingredients
Approved
Quick Info
Agency
PPB
Country
🇰🇪
Approval Date
Jun 21, 2024
Approval ID
d13fe05d3fcc5839
Type
Standard
Back to PPB Approvals